Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573157 · ClinicalTrials.gov registry record · Phase 2
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2 study, sponsored by EMD Serono.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00573157 is a Phase 2 study that was terminated before completion, run by EMD Serono. The registered enrollment target is 6 participants.
The verdict
NCT00573157, a Phase 2 study, was terminated before completion, sponsored by EMD Serono.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether atacicept treatment leads to improvement in kidney function in subjects with active lupus nephritis in combination with mycophenolate mofetil (MMF) and corticosteroids. The study was sponsored by Merck Serono International; operational oversight was provided by ZymoGenetics.
Interventions
- DRUG Placebo
- DRUG Corticosteroids
- DRUG Mycophenolate mofetil
- DRUG Atacicept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00573157
The ClinicalTrials.gov registry entry for NCT00573157 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMD Serono, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00573157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00573157 about?
NCT00573157 is a clinical study titled "The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis". The purpose of this study is to learn whether atacicept treatment leads to improvement in kidney function in subjects with active lupus nephritis in combination with mycophenolate mofetil (MMF) and corticosteroids. The study was sponsored by Merck Serono International; operational oversight was prov...
What is the current status of trial NCT00573157?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2007-12. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00573157?
The interventions under investigation include: Placebo (DRUG), Corticosteroids (DRUG), Mycophenolate mofetil (DRUG), Atacicept (DRUG).
Who is sponsoring clinical trial NCT00573157?
This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.